A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

NCT05984537 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Coronary Microvascular Dysfunction

Interventions

DRUG: Bivalirudin
DRUG: standard heparin

Sponsor

Peking University First Hospital